한국어
English
日本語
中文(简体)
Prigrel Tablet (Clopidogrel Reginate)
150mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Clopidogrel benzenesulfonate is an ingredient that inhibits platelet aggregation and prevents thrombus formation.
MFDS ingredient code M207237
Clopidogrel benzenesulfonate belongs to a class of antiplatelet agents that regulate platelet function. It is primarily used to reduce the risk of thrombus formation due to atherosclerosis. It prevents platelets in the blood from clumping together, thereby preventing thrombus formation in the vessels.
This ingredient disrupts the process of platelets sticking together by blocking specific receptors on the platelet surface. As a result, it reduces the formation of thrombus and lowers the risk of vessel blockage. It thus helps to maintain smooth blood flow.
Approved uses differ by product. Check each product's information for its actual use.
Unlike aspirin, clopidogrel benzenesulfonate selectively inhibits the ADP receptors on platelets. This poses a risk of bleeding, but its mechanism of action and side effect profile differ from other antiplatelet agents. Furthermore, the salt form is different from that of clopidogrel, which may result in variations in absorption or stability.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.